As diabetes care continues to be a significant focus, promising treatments are emerging . Retatrutide, Tirzepatide, and Semaglutide represent a remarkable generation in incretin mimetic medications. While all https://socialinplace.com/story7671653/the-new-drug-vs-tirzepatid-vs-semaglutide-a-comparative-analysis